Skip to content

Clinical trials

Completed Myocardial Infarction trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myocardial Infarction Status: Completed Country / region: Russia Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20062
20071
20083
20091
20101
20112
20134
20144
20151
20171
20183
20192
20202
20214
20222
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed36

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Tomsk National Research Medical Center of the Russian Academy of Sciences4
AstraZeneca3
AO GENERIUM2
Boehringer Ingelheim2
Janssen Research & Development, LLC2
Novartis2
Novartis Pharmaceuticals2
Takeda2
Bayer1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myocardial Infarction36
Stroke10
Acute Coronary Syndrome9
Angina, Unstable6
Coronary Artery Disease5
ST Elevation Myocardial Infarction5
Cardiovascular Diseases4
Heart Failure4
Myocardial Ischemia4
Diabetes Mellitus3

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.